Pfizer Hit by Stronger Dollar, Patent Losses

Pfizer issued downbeat guidance for the new year, citing the stronger U.S. dollar and recent drug-patent losses, and reported declining sales in the most recent period.



from WSJ.com: US Business http://ift.tt/1JW1dMT

via IFTTT